Disease The intractable diseases designated by MHLW, Japan
Diseases : 338 - Clinical trials : 34,520 / Drugs : 19,957 - ( DrugBank : 2,195 ) / Drug target genes : 613 - Drug target pathways : 297
ID | Disease name [Group] | Clinical trial Phase 1 / 2 / 3 / 4 | Drug [ DrugBank ] | Target gene Target pathway | Domestic patients Med expenses recipients (FY2022) |
---|---|---|---|---|---|
47 | Buerger disease [Card] 💬 "Thromboangiitis obliterans" | 9 9 trials | 0 / 3 / 1 / 0 💬 | 14 14 drugs [ 7 7 drugs ] | 5 5 genes 16 pathways | 1609 1,609 patientsAge distribution💬 |
57 | Idiopathic dilated cardiomyopathy [Card] 💬 | 11 11 trials | 3 / 6 / 1 / 3 💬 | 23 23 drugs [ 12 12 drugs ] | 9 9 genes 35 pathways | 18234 18,234 patientsAge distribution💬 |
58 | Hypertrophic cardiomyopathy [Card] 💬 "HCM", "Nonobstructive hypertrophic cardiomyopathy", "Nonobstructive HCM", "Obstructive hypertrophic cardiomyopathy", "Obstructive HCM", "OHCM", "Hypertrophic obstructive cardiomyopathy", "HOCM", "Mid-ventricular obstructive hypertrophic cardiomyopathy", "MVOHCM", "Mid-ventricular hypertrophic obstructive cardiomyopathy", "MVHOCM", "Apical hypertrophic cardiomyopathy", "APH", "Expansion phase hypertrophic cardiomyopathy" | 126 126 trials | 21 / 55 / 43 / 14 💬 | 135 135 drugs [ 42 42 drugs ] | 46 46 genes 162 pathways | 4318 4,318 patientsAge distribution💬 |
59 | Restricted cardiomyopathy [Card] 💬 "Restrictive cardiomyopathy", "Constrictive cardiomyopathy" | 0 - | 0 - | 0 - | 60 60 patientsAge distribution💬 |
167 | Marfan syndrome [Card] 💬 | 21 21 trials | 15 / 6 / 12 / 4 💬 | 40 40 drugs [ 11 11 drugs ] | 10 10 genes 50 pathways | 1173 1,173 patientsAge distribution💬 |
179 | Williams syndrome [Card] 💬 | 5 5 trials | 0 / 0 / 0 / 1 💬 | 14 14 drugs [ 7 7 drugs ] | 8 8 genes 32 pathways | 56 56 patientsAge distribution💬 |
188 | Polysplenia syndrome [Card] 💬 | 0 - | 0 - | 0 - | 63 63 patientsAge distribution💬 |
189 | Asplenia syndrome [Card] 💬 | 0 - | 0 - | 0 - | 91 91 patientsAge distribution💬 |
203 | 22q11.2 deletion syndrome [Card] 💬 | 5 5 trials | 2 / 1 / 1 / 0 💬 | 7 7 drugs [ 1 1 drug ] | 14 14 genes 23 pathways | 73 73 patientsAge distribution💬 |
207 | Persistent truncus arteriosus [Card] 💬 "Persistent truncus arteriosus type I", "Persistent truncus arteriosus type II", "Persistent truncus arteriosus type III", "Persistent truncus arteriosus type IV" | 0 - | 0 - | 0 - | 38 38 patientsAge distribution💬 |
208 | Corrected transposition of great arteries [Card] 💬 | 0 - | 0 - | 0 - | 208 208 patientsAge distribution💬 |
209 | Complete transposition of great vessel [Card] 💬 "Complete transposition of great arteries", "Complete TGA", "Complete transposition of great vessel type I", "Complete transposition of great arteries type I", "Complete TGA type I", "Complete transposition of great vessel type II", "Complete transposition of great arteries type II", "Complete TGA type II", "Complete transposition of great vessel type III", "Complete transposition of great arteries type III", "Complete TGA type III", "Complete transposition of great vessel type IV", "Complete transposition of great arteries type IV", "Complete TGA type IV" | 0 - | 0 - | 0 - | 288 288 patientsAge distribution💬 |
210 | Single Ventricle [Card] 💬 "SV", "Single ventricle heart defect", "Univentricular heart", "UVH", "Single ventricular circulation syndrome" | 51 51 trials | 23 / 15 / 24 / 6 💬 | 53 53 drugs [ 22 22 drugs ] | 32 32 genes 67 pathways | 479 479 patientsAge distribution💬 |
211 | Hypoplastic left heart syndrome [Card] 💬 "HLHS" | 22 22 trials | 10 / 11 / 1 / 0 💬 | 29 29 drugs [ 9 9 drugs ] | 5 5 genes 14 pathways | 70 70 patientsAge distribution💬 |
212 | Tricuspid atresia [Card] 💬 "TA" | 5 5 trials | 2 / 2 / 0 / 0 💬 | 6 6 drugs [ 6 6 drugs ] | 8 8 genes 12 pathways | 199 199 patientsAge distribution💬 |
213 | Pulmonary atresia without ventricular septum defect [Card] 💬 "Pulmonary atresia with intact ventricular septum", "Pulmonary atresia" | 0 - | 0 - | 0 - | 157 157 patientsAge distribution💬 |
214 | Pulmonary atresia with ventricular septum defect [Card] 💬 "PAVSD", "Pulmonary atresia with ventricular septal defect", "Pulmonary atresia", "Tetralogy of Fallot with pulmonary atresia", "TFPA" | 2 2 trials | 0 / 0 / 0 / 0 💬 | 4 4 drugs [ 4 4 drugs ] | 0 - | 123 123 patientsAge distribution💬 |
215 | Tetralogy of Fallot [Card] 💬 "Fallot tetralogy" | 18 18 trials | 4 / 5 / 2 / 1 💬 | 26 26 drugs [ 14 14 drugs ] | 13 13 genes 45 pathways | 760 760 patientsAge distribution💬 |
216 | Double outlet right ventricle [Card] 💬 | 0 - | 0 - | 0 - | 286 286 patientsAge distribution💬 |
217 | Ebstein disease [Card] 💬 "Ebstein malformation" | 0 - | 0 - | 0 - | 141 141 patientsAge distribution💬 |
279 | Huge venous malformation with cervical, oral and pharyngeal diffuse lesion [Card] 💬 oral and pharyngeal diffuse lesion", "Huge venous malformation", "Venous malformation" | 15 15 trials | 1 / 7 / 1 / 2 💬 | 24 24 drugs [ 10 10 drugs ] | 3 3 genes 105 pathways | 49 49 patientsAge distribution💬 |
280 | Huge arteriovenous malformation with cervicofacial or limb lesion [Card] 💬 "Huge arteriovenous malformation", "Arteriovenous malformation" | 27 27 trials | 14 / 7 / 2 / 6 💬 | 30 30 drugs [ 15 15 drugs ] | 14 14 genes 153 pathways | 103 103 patientsAge distribution💬 |
281 | Klippel-Trenaunay-Weber syndrome [Card] 💬 "Klippel-Trenauney-Weber syndrome", "Klippel-Trenaunay syndrome", "Klippel-Trenauney syndrome", "KTS", "Parkes Weber syndrome", "PWS" | 2 2 trials | 0 / 0 / 0 / 0 💬 | 2 2 drugs [ 1 1 drug ] | 1 1 gene 51 pathways | 244 244 patientsAge distribution💬 |
311 | Congenital tricuspid stenosis [Card] 💬 | 0 - | 0 - | 0 - | 4 4 patientsAge distribution💬 |
312 | Congenital mitral stenosis [Card] 💬 | 0 - | 0 - | 0 - | 13 13 patientsAge distribution💬 |
313 | Congenital pulmonary vein stenosis [Card] 💬 | 0 - | 0 - | 0 - | 2 2 patientsAge distribution💬 |
314 | Vascular sling [Card] 💬 | 0 - | 0 - | 0 - | 2 2 patientsAge distribution💬 |